ISCC-PEG Pharmacogenomics Learning Series
The Pharmacogenomics (PGx) Project Group has developed peer-reviewed online education for healthcare practitioners to advance pharmacogenomics in clinical practice. The activities below can be taken independently free of charge. The content is reviewed annually and the series is hosted online by the University of Pittsburgh.
Available Modules
Pharmacogenomics Nomenclature
Educates healthcare professionals about pharmacogenomics nomenclature and how to apply pharmacogenomics information into clinical decision making.
Author: Spoorthy Reddy, BS.
External Reviewers: Christina Aquilante, Pharm.D. and Kathleen Giacomini, Ph.D.
Pharmacogenomics Resources
Educates healthcare professionals about evidence-based pharmacogenomic resources from the Food and Drug Administration (FDA), the Clinical Pharmacogenetics Implementation Consortium (CPIC), and the Pharmacogenomics Knowledgebase (PharmGKB).
Authors: Philip Empey, Pharm.D., Ph.D. and Ben Brown, B.S.
External Reviewers: Kelly Caudle, Pharm.D., Ph.D. and Wendy Rubinstein, M.D., Ph.D.
Practical Aspects of Pharmacogenomics Implementation
Educates healthcare professionals about what elements are involved in implementing a simple population-focused, pharmacogenomic program.
Authors: Otito Frances Iwuchukwu, PharmD, PhD and Jenny Nguyen, PharmD, APh, BCPS
External Reviewers: Natasha Petry, PharmD, BCACP and Vivian K. Kawai, MD, MPH
Direct-to-Consumer Pharmacogenomic Testing
Educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
Author: Roseann S. Donnelly (Gammal), PharmD, BCPS
External Reviewers: Cyrine-Elaina Haidar, PharmD, BCPS, BCOP, FASHP and David Kisor, PharmD, FCP
Economics of Pharmacogenomic Testing
Provides a case study to demonstrate treatment regimen decisions through cost-benefit analysis based on genetic testing, individual patient medical information, and risk factors.
Author: Karen Niemchick, Ph.D.
External Reviewers: Joshua Peterson, M.D. and Caleb Bupp, M.D.
Navigating Pharmacogenomics Test Coverage in Medicare Populations
Explores key components of Medicare payer coverage guidance for pharmacogenomics testing including technical and documentation requirements.
Authors: BS, Christine Formea, Pharm.D., and Sara Rogers, Pharm.D., BCPS; Christine Formea, PharmD, BCPS, FCCP, FASHP; and Ben Brown, B.S.
External Reviewers: Jai Patel, Pharm.D., BCOP, CPP and Chet Robson, D.O., MHCDS, FAAFP
Last updated: July 31, 2024